The effect of protease inhibitors on the polyclonal B cell activator from the serum of patients with rheumatoid arthritis
- 1 January 1982
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 4 (1) , 1-7
- https://doi.org/10.1016/0192-0561(82)90002-9
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Treatment of chronic urticaria with a proteinase (kallikrein) inhibitorBritish Journal of Dermatology, 2006
- The turnover of surface immunoglobulins of small lymphocytes and blastic cellsCellular Immunology, 1980
- Helper factors derived from autologous mixed lymphocyte culturesCellular Immunology, 1980
- Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors.The Journal of Experimental Medicine, 1979
- Con-A-activated T Cells Secrete Factors with Polyclonal B-Cell-activating PropertiesScandinavian Journal of Immunology, 1979
- T-independent but not T-dependent Antigens maintain surface ig of lymphocytesCellular Immunology, 1979
- Human Leucocyte Response to Migration Inhibitory Activity from LymphocytesActa Medica Scandinavica, 1978
- The polyvalent protease inhibitor, trasylol, inhibits DNA synthesis of mouse lymphocytes by an indirect mechanismCellular Immunology, 1977
- Induction of autoantibodies to red blood cells by polyclonal B-cell activatorsNature, 1976
- A MODIFIED SPECTROPHOTOMETRIC DETERMINATION OF CHYMOTRYPSIN, TRYPSIN, AND THROMBINCanadian Journal of Biochemistry and Physiology, 1959